Trial
NCT03074318
Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI); EMD Serono
Condition
Metastatic Leiomyosarcoma
Intervention
Avelumab
Why stopped
Terminated due to PI leaving institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-29